Unichem Labs receives ANDA approval for Zonisamide Capsules from USFDA

The product will be commercialized from Unichem’s Goa Plant.

Jan 27, 2021 04:01 IST India Infoline News Service

Unichem
Unichem Laboratories Limited has announced hat it has received ANDA approval for its Zonisamide Capsules, USP 25 mg, 50 mg and 100 mg. 

United States Food and Drug Administration (USFDA) has approved the company to market a generic version of Zonegran (Zonisamide) Capsules of Sunovion Pharmaceuticals Inc.

Zonisamide Capsules are indicated as adjunctive therapy in the treatment of partial seizures in adults with epilepsy.

The product will be commercialized from Unichem’s Goa Plant.

Unichem Labs ended at Rs289.05 down by Rs4.85 or 1.65% from its previous closing of Rs293.90 on the BSE.

Related Story

Open Free Demat Account (Rs699)
Open ZERO Brokerage Demat Account

  • 0

    Delivery Brokerage for Lifetime

  • 20

    Per order for Intraday, F&O, Currency & Commodity